The double-stranded RNA-dependent protein kinase PKR: Structure and function

Journal of Interferon and Cytokine Research

Volumn 17, Issue 9, 1997, Pages 503-524

  Clemens, Michael J ^a   Elia, Androulla ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; ENZYME ACTIVATOR; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 3; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; CANCER INHIBITION; DIMERIZATION; ENZYME STRUCTURE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; REVIEW; RNA BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRUS INHIBITION;

ANIMALIA;

EID: 0030725442     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.503     Document Type: Review

References (224)

1. HUNTER, T., HUNT, T., JACKSON, R.J., and ROBERTSON, H.D. (1975). The characteristics of inhibition of protein synthesis by double-stranded ribonucleic acid in reticulocyte lysates. J. Biol. Chem. 250, 409-417.
2. CLEMENS, M.J., SAFER, B., MERRICK, W.C., ANDERSON, W.F., and LONDON, I.M. (1975). Inhibition of protein synthesis in rabbit reticulocyte lysates by double-stranded RNA and oxidized glutathione: indirect mode of action on polypeptide chain initiation. Proc. Natl. Acad. Sci. USA 72, 1286-1290.
3. FARRELL, P.J., BALKOW, K., HUNT, T., JACKSON, R.J., and TRACHSEL, H. (1977). Phosphorylation of initiation factor eIF-2 and control of reticulocyte protein synthesis. Cell 11, 187-200.
4. LEVIN, D., and LONDON, I.M. (1978). Regulation of protein synthesis: activation by double-stranded RNA of a protein kinase that phosphorylates eukaryotic initiation factor 2. Proc. Natl. Acad. Sci. USA 75, 1121-1125.
5. LEVIN, D.H., PETRYSHYN, R., and LONDON, I.M. (1980). Characterization of a double-stranded RNA-activated kinase that phosphorylates alpha subunit of eukaryotic initiation factor 2 (eIF-2α) in reticulocyte lysates. Proc. Natl. Acad. Sci. USA 77, 832-836.
6. FARRELL, P.J., SEN, G.C., DUBOIS, M.F., RATNER, L., SLATTERY, E., and LENGYEL, P. (1978). Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA. Proc. Natl. Acad. Sci. USA 75, 5893-5897.
7. ROBERTS, W.K., CLEMENS, M.J., and KERR, I.M. (1976). Interferon-induced inhibition of protein synthesis in L-cell extracts: an ATP-dependent step in the activation of an inhibitor by double-stranded RNA. Proc. Natl. Acad. Sci. USA 73, 3136-3140.
8. ZILBERSTEIN, A., FEDERMANN, P., SCHULMAN, L., and REVEL, M. (1976). Specific phosphorylation in vitro of a protein associated with ribosomes of interferon-treated mouse L cells. FEBS Lett. 68, 119-124.
9. SAMUEL, C.E. (1979). Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase possessing site specificity similar to hemin regulated rabbit reticulocyte kinase. Proc. Natl. Acd. Sci. USA 76, 600-604.
10. SAMUEL, C.E., DUNCAN, R., KNUTSON, G.S., and HERSHEY, J.W.B. (1984). Mechanism of interferon action. Increased phosphorylation of protein synthesis initiation factor eIF-2(alpha) in interferon-treated, reovirus-infected mouse L929 fibroblasts in vitro and in vivo. J. Biol. Chem. 259, 13451-13457.
11. RICE, A.P., DUNCAN, R., HERSHEY, J.W.B., and KERR, I.M. (1985). Double-stranded RNA-dependent protein kinase and 2-5A system are both activated in interferon-treated, encephalomyocarditis virus-infected HeLa cells. J. Virol. 54, 894-898.
12. KRUST, B., GALABRU, J., and HOVANESSIAN, A.G. (1984). Further characterization of the protein kinase activity mediated by interferon in mouse and human cells. J. Biol. Chem. 259, 8494-8496.
13. HOVANESSIAN, A.G. (1989). The double-stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. J. Interferon Res. 9, 641-647.
14. CLEMENS, M.J., HERSHEY, J.W.B., HOVANESSIAN, A.C., JACOBS, B.C., KATZE, M.G., KAUFMAN, R.J., LENGYEL, P., SAMUEL, C.E., SEN, G.C., and WILLIAMS, B.R.G. (1993). PKR: proposed nomenclature for the RNA-dependent protein kinase induced by interferon. J. Interferon Res. 13, 241.
15. SAMUEL, C.E. (1993). The eIF-2α protein kinases, regulators of translation in eukaryotes from yeasts to humans. J. Biol. Chem. 268, 7603-7606.
16. CLEMENS, M.J. (1994). Regulation of eukaryotic protein synthesis by protein kinases that phosphorylate initiation factor eIF-2. Mol. Biol. Reports 19, 201-210.
17. CLEMENS, M.J. (1996). Protein kinases that phosphorylate eIF2 and eIF2B, and their role in eukaryotic cell translational control. In: Translational Control. J.W.B. Hershey, M.B. Mathews, and N. Sonenberg (eds.) Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, pp. 139-172.
18. LANGLAND, J.O., JIN, S., JACOBS, B.L., and ROTH, D.A. (1995). Identification of a plant-encoded analog of PKR, the mammalian double-strnaded RNA-dependent protein kinase. Plant Physiol. 108, 1259-1267.
19. LANGLAND, J.O., LANGLAND, L.A., BROWNING, K.S., and ROTH, D.A. (1996). Phosphorylation of plant eukaryotic initiation factor-2 by the plant-encoded double-stranded RNA-dependent protein kinase, pPKR, and inhibition of protein synthesis in vitro. J. Biol. Chem. 271, 4539-4544.
20. DE HARO, C., MÉNDEZ, R., and SANTOYO, J. (1996). The eIF-2α kinases and the control of protein synthesis. FASEB J. 10, 1378-1387.
21. MATHEWS, M.B., GUNNERY, S., MANCHE, L., MELLITS, K.H., and PE'ERY, T. (1990). Control of protein synthesis by RNA regulators. NATO Adv. Sci. Inst. Ser. H Cell. Biol. 49, 377-388.
22. JARAMILLO, M.L., ABRAHAM, N., and BELL, J.C. (1995). The interferon system: a review with emphasis on the role of PKR in growth control. Cancer Invest. 13, 327-338.
23. PROUD, C.G. (1995). PKR: a new name and new roles. Trends Biochem. Sci. 20, 241-246.
24. WILLIAMS, B.R.G. (1995). The role of the dsRNA-activated kinase, PKR, in signal transduction. Semin. Virol. 6, 191-202.
25. JACOBS, B.L., and LANGLAND, J.O. (1996). When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219, 339-349.
26. PETRYSHYN, R.A., LI, J., and JUDWARE, R. (1994). Activation of the dsRNA-dependent kinase. Prog. Mol. Subcell. Biol. 14, 1-14.
27. ROBERTSON, H.D., and MATHEWS, M.B. (1996). The regulation of the protein kinase PKR by RNA. Biochimie 78, 909-914.
28. TANAKA, H., and SAMUEL, C.E. (1994). Mechanism of interferon action: structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 91, 7995-7999.
29. TANAKA, H., and SAMUEL, C.E. (1995). Sequence of the murine interferon-inducible RNA-dependent protein kinase (PKR) deduced from genomic clones. Gene 153, 283-284.
30. KUHEN, K.L., SHEN, X.Y., CARLISLE, E.R., RICHARDSON, A.L., WEIER, H.U.G., TANAKA, H., and SAMUEL, C.E. (1996). Structural organization of the human gene (PKR) encoding an interferon-inducible RNA-dependent protein kinase (PKR) and differences from its mouse homolog. Genomics 36, 197-201.
31. KUHEN, K.L., SHEN, X.Y., and SAMUEL, C.E. (1996). Mechanism of interferon action - sequence of the human interferon-inducible RNA-dependent protein kinase (PKR) deduced from genomic clones. Gene 178, 191-193.
32. BARBER, G.N., EDELHOFF, S., KATZE, M.G., and DISTECHE, C.M. (1993). Chromosomal assignment of the interferon-inducible double-stranded RNA-dependent protein kinase (PRKR) to human chromosome 2p21-p22 and mouse chromosome 17 E2. Genomics 16, 765-767.
33. SQUIRE, J., MEURS, E.F., CHONG, K.L., McMILLAN, N.A.J., HOVANESSIAN, A.G., and WILLIAMS, B.R.G. (1993). Localization of the human interferon-induced, ds-RNA activated p68 kinase gene (PRKR) to chromosome 2p21-p22. Genomics 16, 768-770.
34. KUHEN, K.L., and SAMUEL, C.E. (1997). Isolation of the interferon-inducible RNA-dependent protein kinase Pkr promoter and identification of a novel DNA element within the 5′-flanking region of human and mouse Pkr genes. Virology 227, 119-130.
35. MEURS, E., CHONG, K., GALABRU, J., THOMAS, N.S.B., KERR, I.M., WILLIAMS, B.R.G., and HOVANESSIAN, A.G. (1990). Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62, 379-390.
36. BAIER, L.J., SHORS, T., SHORS, S.T., and JACOBS, B.L. (1993). The mouse antiphosphotyrosine immunoreactive kinase, TIK, is indistinguishable from the double-stranded RNA-dependent, interferon-induced protein kinase, PKR. Nucleic Acids Res. 21, 4830-4835.
37. MELLOR, H., FLOWERS, K.M., KIMBALL, S.R., and JEFFERSON, L.S. (1994). Cloning and characterization of a cDNA encoding rat PKR, the double-stranded RNA-dependent eukaryotic initiation factor-2 kinase. Biochim. Biophys. Acta 1219, 693-696.
38. PATEL, R.C., and SEN, G.C. (1992). Identification of the double-stranded RNA-binding domain of the human interferon-inducible protein kinase. J. Biol. Chem. 267, 7671-7676.
39. McCORMACK, S.J., ORTEGA, L.G., DOOHAN, J.P., and SAMUEL, C.E. (1994). Mechanism of interferon action: motif I of the interferon-induced, RNA-dependent protein kinase (PKR) is sufficient to mediate RNA-binding activity. Virology 198, 92-99.
40. KATZE, M.G., WAMBACH, M., WONG, M-L., GARFINKEL, M., MEURS, E., CHONG, K., WILLIAMS, B.R.G., HOVANESSIAN, A.G., and BARBER, G.N. (1991). Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system. Mol. Cell. Biol. 11, 5497-5505.
41. GREEN, S.R., and MATHEWS, M.B. (1992). Two RNA-binding motifs in the double-stranded RNA-activated protein kinase, DAI. Genes Dev. 6, 2478-2490.
42. McCORMACK, S.J., THOMIS, D.C., and SAMUEL, C.E. (1992). Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2α protein kinase. Virology 188, 47-56.
43. PATEL, R.C., STANTON, P., and SEN, G.C. (1994). Role of the amino-terminal residues of the interferon-induced protein kinase in its activation by double-stranded RNA and heparin. J. Biol. Chem. 269, 18593-18598.
44. CLARKE, P.A., and MATHEWS, M.B. (1995). Interaction between the double-stranded RNA binding motif and RNA: definition of the binding site for the interferon-induced protein kinase DAI (PKR) on adenovirus VA RNA. RNA 1, 7-20.
45. SCHMEDT, C., GREEN, S.R., MANCHE, L., TAYLOR, D.R., MA, Y., and MATHEWS, M.B. (1995). Functional characterization of the RNA-binding domain and motif of the double-stranded RNA-dependent protein kinase DAI (PKR). J. Mol. Biol. 249, 29-44.
46. McMILLAN, N.A.J., CARPICK, B.W., HOLLIS, B., TOONE, W.M., ZAMANIAN-DARYOUSH, M., and WILLIAMS, B.R.G. (1995). Mutational analysis of the double-stranded RNA (dsRNA) binding domain of the dsRNA-activated protein kinase, PKR. J. Biol. Chem. 270, 2601-2606.
47. PATEL, R.C., STANTON, P., and SEN, G.C. (1996). Specific mutations near the amino terminus of double-stranded RNA-dependent protein kinase (PKR) differentially affect its double-stranded RNA binding and dimerization properties. J. Biol. Chem. 271, 25657-25663.
48. NEKHAI, S., KUMAR, A., BOTTARO, D.P., and PETRYSHYN, R. (1996). Peptides derived from the interferon-induced PKR prevent activation by HIV-1 TAR RNA. Virology 222, 193-200.
49. ST JOHNSTON, D., BROWN, N.H., GALL, J.G., and JANTSCH, M. (1992). A conserved double-stranded RNA-binding domain. Proc. Natl. Acad. Sci. USA 89, 10979-10983.
50. HATADA, E., and FUKUDA, R. (1992). Binding of influenza virus NS1 protein to dsRNA in vitro. J. Gen. Virol. 73, 3325-3329.
51. CHANG, H.-W., and JACOBS, B.L. (1993). Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA. Virology 19-4, 537-547.
52. MABROUK, T., DANIS, C., and LEMAY, G. (1995). Two basic motifs of reovirus σ3 protein are involved in double-stranded RNA binding. Biochem. Cell Biol. 73, 137-145.
53. HO, C.K., and SHUMAN, S. (1996). Mutational analysis of the vaccinia virus E3 protein defines amino acid residues involved in E3 binding to double-stranded RNA. J. Virol. 70, 2611-2614.
54. BASS, B.L., HURST, S.R., and SINGER, J.D. (1994). Binding properties of newly identified Xenopus proteins containing dsRNA-binding motifs. Curr. Biol. 4, 301-314.
55. KROVAT, B.C., and JANTSCH, M.F. (1996). Comparative mutational analysis of the double-stranded RNA binding domains of Xenopus laevis RNA-binding protein A. J. Biol. Chem. 271, 28112-28119.
56. BYCROFT, M., GRÜNERT, S., MURZIN, A.G., PROCTOR, M., and ST JOHNSTON, D. (1995). NMR solution structure of a dsRNA binding domain from Drosophila staufen protein reveals homology to the N-terminal domain of ribosomal protein S5. EMBO J. 14, 3563-3571.
57. LIU, Z-R., WILKIE, A.M., CLEMENS, M.J., and SMITH, C.W.J. (1996). Detection of double-stranded RNA-protein interactions by methylene blue-mediated photo-crosslinking. RNA 2, 611-621.
58. KHARRAT, A., MACIAS, M.J., GIBSON, T.J., NILGES, M., and PASTURE, A. (1995). Structure of the dsRNA binding domain of E. coli RNase III. EMBO J. 14, 3572-3584.
59. STEITZ, T.A. (1990). Structural studies of protein-nucleic acid interaction: the sources of sequence-specific binding. Q. Rev. Biophys. 23, 205-280.
60. BEVILACQUA, P.C., and CECH, T.R. (1996). Minor-groove recognition of double-stranded RNA by the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR. Biochemistry 35, 9983-9994.
61. MANCHE, L., GREEN, S.R., SCHMEDT, C., and MATHEWS, M.B. (1992). Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol. Cell. Biol. 12, 5238-5248.
62. WEK, R.C. (1994). eIF-2 kinases: Regulators of general and genespecific translation initiation. Trends Biochem. Sci. 19, 491-496.
63. CHONG, K.L., FENG, L., SCHAPPERT, K., MEURS, E., DONAHUE, T.F., FRIESEN, J.D., HOVANESSIAN, A.G., and WILLIAMS, B.R.G. (1992). Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J. 11, 1553-1562.
64. CRAIG, A.W.B., COSENTINO, G.P., DONZÉ, O., and SONENBERG, N. (1996). The kinase insert domain of interferon-induced protein kinase PKR is required for activity but not for interaction with the pseudosubstrate K3L. J. Biol. Chem. 271, 24526-24533.
65. IPK and vaccinia virus K3L is mediated by unique domains: implications for kinase regulation. Mol. Cell. Biol. 16, 4172-4181.
66. KIRCHHOFF, S., KOROMILAS, A.E., SCHAPER, F., GRASHOFF, M., SONENBERG, N., and HAUSER, H. (1995). IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene 11, 439-445.
67. BERETTA, L., GABBAY, M., BERGER, R., HANASH, S.M., and SONENBERG, N. (1996). Expression of the protein kinase PKR is modulated by IRF-1 and is reduced in 5q-associated leukemias. Oncogene 12, 1593-1596.
68. GALABRU, J., and HOVANESSIAN, A. (1987). Autophoshorylation of the protein kinase dependent on double-stranded RNA. J. Biol. Chem. 262, 15538-15544.
69. JEFFREY, I.W., KADEREIT, S., MEURS, E.F., METZGER, T., BACHMANN, M., SCHWEMMLE, M., HOVANESSIAN, A.G., and CLEMENS, M.J. (1995). Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells. Exp. Cell Res. 218, 17-27.
70. r = 66,000 subunits. J. Biol. Chem. 267, 10729-10736.
71. I in adenovirus-infected HeLa cells. J. Cell Sci. 106, 11-22.
72. YEUNG, M.C., LIU, J., and LAU, A.S. (1996). An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proc. Natl. Acad. Sci. USA 93, 12451-12455.
73. SALZBERG, S., MANDELBAUM, M., ZALCBERG, M., and SHAINBERG, A. (1995). Interruption of myogenesis by transforming growth factor β1 or EGTA inhibits expression and activity of the myogenic-associaled (2′-5′) oligoadenylate synthetase and PKR. Exp. Cell Res. 219, 223-232.
74. KORTH, M.J., LYONS, C.N., WAMBACH, M., and KATZE, M.G. (1996). Cloning, expression, and cellular localization of the oncogenic 58-kDa inhibitor of the RNA-activated human and mouse protein kinase. Gene 170, 181-188.
75. KATZE, M.G., TOMITA, J., BLACK, T., KRUG, R.M., SAFER, B., and HOVANESSIAN, A. (1988). Influenza virus regulates protein synthesis during infection by repressing autophosphorylation and activity of the cellular 68,000-Mr protein kinase. J. Viral. 62, 3710-3717.
76. POLYAK, S.J., TANG, N., WAMBACH, M., BARBER, G.N., and KATZE, M.G. (1996). The P58 cellular inhibitor complexes with the interferon-induced, double-stranded RNA-dependent protein kinase, PKR, to regulate its autophosphorylation and activity. J. Biol. Chem. 271, 1702-1707.
77. TANG, N.M., HO, C.Y., and KATZE, M.G. (1996). The 58-kDa cellular inhibitor of the double stranded RNA-dependent protein kinase requires the tetratricopeptide repeat 6 and DnaJ motifs to stimulate protein synthesis in vivo. J. Biol. Chem. 271, 28660-28666.
78. MELVILLE, M.W., HANSEN, W.J., FREEMAN, B.C., WELCH, W.J., and KATZE, M.G. (1997). The molecular chaperone hsp40 regulates the activity of P58IPK, the cellular inhibitor of PKR. Proc. Natl. Acad. Sci. USA 94, 97-102.
79. THOMIS, D.C., and SAMUEL, C.E. (1993). Mechanism of interferon action: evidence for intermolecular autophosphorylation and autoactivation of the interferon-induced, RNA-dependent protein kinase PKR. J. Virol. 67, 7695-7700.
80. THOMIS, D.C., and SAMUEL, C.E. (1995). Mechanisms of interferon action: characterization of the intermolecular autophosphorylation of PKR, the interferon-inducible, RNA-dependent protein kinase. J. Virol. 69, 5195-5198.
81. TAYLOR, D.R., LEE, S.B., ROMAND, P.R., MARSHAK, D.R., HINNEBUSCH, A.G., ESTEBAN, M., and MATHEWS, M.B. (1996). Autophosphorylation sites participate in the activation of the double-stranded RNA-activated protein kinase PKR. Mol. Cell. Biol. 16, 6295-6302.
82. KOSTURA, M., and MATHEWS, M.B. (1989). Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI. Mol. Cell. Biol. 9, 1576-1586.
83. GALABRU, J., KATZE, M.G., ROBERT, N., and HOVANESSIAN, A.G. (1989). The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase. Eur. J. Biochem. 178, 581-589.
84. 1 RNA. Nucleic Acids Res. 21, 4483-4490.
85. ROMANO, P.R., GREEN, S.R., BARBER, G.N., MATHEWS, M.B., and HINNEBUSCH, A.G. (1995). Structural requirements for double-stranded RNA binding, dimerization, and activation of the human eIF-2α kinase DAI in Saccharomyces cerevisiae. Mol. Cell. Biol. 15, 365-378.
86. WU, S.Y., and KAUFMAN, R.J. (1997). A model for the double-stranded RNA (dsRNA)-dependent dimerization and activation of the dsRNA-activated protein kinase PKR. J. Biol. Chem. 272, 1291-1296.
87. CARPICK, B.W., GRAZIANO, V., SCHNEIDER, D., MAITRA, R.K., LEE, X., and WILLIAMS, B.R.G. (1997). Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase PKR and HIV-1 TAR RNA. J. Biol. Chem. 272, 9510-9516.
88. MARAN, A., and MATHEWS, M.B. (1988). Characterization of the double-stranded RNA implicated in the inhibition of protein synthesis in cells infected with a mutant adenovirus defective for VA RNAI. Virology 164, 106-113.
89. DAVIS, S., and WATSON, J.C. (1996). In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA, from the 3′ untranslated regions of human α-tropomyosin. Proc. Natl. Acad. Sci. USA 93, 508-513.
90. PRATT, G., GALPINE, A.R., SHARP, N.A., PALMER, S., and CLEMENS, M.J. (1988). Regulation of in vitro translation by double-stranded RNA in mammalian cell mRNA preparations. Nucleic Acids Res. 16, 3497-3510.
91. GEORGE, C.X., THOMIS, D.C., McCORMACK, S.J., SVAHN, C.M., and SAMUEL, C.E. (1996). Characterization of the heparin-mediated activation of PKR, the interferon-inducible RNA-dependent protein kinase. Virology 221, 180-188.
92. LEE, S.B., GREEN, S.R., MATHEWS, M.B., and ESTEBAN, M. (1994). Activation of the double-stranded RNA (dsRNA)-activated human protein kinase in vivo in the absence of its dsRNA binding domain. Proc. Natl. Acad. Sci. USA 91, 10551-10555.
93. RICE, A.P., KOSTURA, M., and MATHEWS, M.B. (1989). Identification of a 90-kDa polypeptide which associates with adenovirus VA RNAI and is phosphorylated by the double-stranded RNA-dependent protein kinase. J. Biol. Chem. 264, 20632-20637.
94. ITO, T., JAGUS, R., and MAY, W.S. (1994). Interleukin 3 stimulates protein synthesis by regulating double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 91, 7455-7459.
95. 34.5- mutants of herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 92, 10516-10520.
96. MURTHA-RIEL, P., DAVIES, M.V., SCHERER, B.J., CHOI, S.-Y., HERSHEY, J.W.B., and KAUFMAN, R.J. (1993). Expression of a phosphorylation-resistant eukaryotic initiation factor 2α-subunit mitigates heat shock inhibition of protein synthe-sis. J. Biol. Chem. 268, 12946-12951.
97. BROSTROM, C.O., PROSTKO, C.R., KAUFMANN, R.J., and BROSTROM, M.A. (1996). Inhibition of translational initiation by activators of the glucose-regulated stress protein and heat shock protein stress response systems - role of the interferon-inducible double-stranded RNA-activated eukaryotic initiation factor 2α kinase. J. Biol. Chem. 271, 24995-25002.
98. SCORSONE, K.A., PANNIERS, R., ROWLANDS, A.G., and HENSHAW, E.C. (1987). Phosphorylation of eukaryotic initiation factor 2 during physiological stresses which affect protein synthesis. J. Biol. Chem. 262, 14538-14543.
99. CLEMENS, M.J., GALPINE, A., AUSTIN, S.A., PANNIERS, R., HENSHAW, E.C., DUNCAN, R., HERSHEY, J.W.B., and POLLARD, J.W. (1987). Regulation of polypeptide chain initiation in Chinese hamster ovary cells with a temperature-sensitive leucyl-tRNA synthetase. J. Biol. Chem. 262, 767-771.
100. ROWLANDS, A.G., MONTINE, K.S., HENSHAW, E.C., and PANNIERS, R. (1988). Physiological stresses inhibit guanine-nucleotide-exchange factor in Ehrlich cells. Eur. J. Biochem. 175, 93-99.
101. BROSTROM, C.O., and BROSTROM, M.A. (1990). Calcium-dependent regulation of protein synthesis in intact mammalian cells. Annu. Rev. Physiol. 52, 577-590.
102. 3 pituitary cells by perturbants of early protein processing that induce GRP78. J. Biol. Chem. 267, 16751-16754.
103. PROSTKO, C.R., BROSTROM, M.A., and BROSTROM, C.O. (1993). Reversible phosphorylation of eukaryotic initiation factor 2α in response to endoplasmic reticular signaling. Mol. Cell. Biochem. 127-128, 255-265.
104. BROSTROM, M.A., PROSTKO, C.R., GMITTER, D., and BROSTROM, C.O. (1995). Independent signaling of grp78 gene transcription and phosphorylation of eukaryotic initiation factor 2α by the stressed endoplasmic reticulum. J. Biol. Chem. 270, 4127-1132.
105. PROSTKO, C.R., DHOLAKIA, J.N., BROSTROM, M.A., and BROSTROM, C.O. (1995). Activation of the double-stranded RNA-regulated protein kinase by depletion of endoplasmic reticular calcium stores. J. Biol. Chem. 270, 6211-6215.
106. SRIVASTAVA, S.P., DAVIES, M.V., and KAUFMAN, R.J. (1995). Calcium depletion from the endoplasmic reticulum activates the double-stranded RNA-dependent protein kinase (PKR) to inhibit protein synthesis. J. Biol. Chem. 270, 16619-16624.
107. KORTH, M.J., EDELHOFF, S., DISTECHE, C.M., and KATZE, M.G. (1996). Chromosomal assignment of the gene encoding the human 58-kDa inhibitor (PRKRI) of the interferon-induced dsRNA-activated protein kinase to chromosome 13q32. Genomics 31, 238-239.
108. 2+ ionophore-treated cultured neuronal cells. Neurosci. Lett. 201, 215-218.
109. LEE, S.B., and ESTEBAN, M. (1994). The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 199, 491-496.
110. TAKIZAWA, T., OHASHI, K., and NAKANISHI, Y. (1996). Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J. Virol. 70, 8128-8132.
111. DER, S.D., YANG, Y.-L., WEISSMANN, C., and WILLIAMS, B.R.G. (1997). A PKR-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 3279-3283.
112. KIBLER, K.V., SHORS, T., PERKINS, K.B., ZEMAN, C.C., BANASZAK, M.P., BIESTERFELDT, J., LANGLAND, J.O., and JACOBS, B.L. (1997). Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J. Virol. 71, 1992-2003.
113. PATEL, R.C., STANTON, P., McMILLAN, N.M.J., WILLIAMS, B.R.G., and SEN, G.C. (1995). The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo. Proc. Natl. Acad. Sci. USA 92, 8283-8287.
114. COSENTINO, G.P., VENKATESAN, S., SERLUCA, F.C., GREEN, S.R., MATHEWS, M.B., and SONENBERG, N. (1995). Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. Proc. Natl. Acad. Sci. USA 92, 9445-9449.
115. BISCHOFF, J.R., and SAMUEL, C.E. (1989). Mechanism of interferon action: activation of the human P1/eIF-2α protein kinase by individual reovirus s-class mRNAs: s1 mRNA is a potent activator relative to s4 mRNA. Virology 172, 106-115.
116. HENRY, G.L., McCORMACK, S.J., THOMIS, D.C., and SAMUEL, C.E. (1994). Mechanism of interferon action. Translational control and the RNA-dependent protein kinase (PKR): antagonists of PKR enhance the translational activity of mRNAs that include a 161 nucleotide region from reovirus S1 mRNA. J. Biol. Regul. Homeost. Agents 8, 15-24.
117. ROBERTSON, H.D., MANCHE, L., and MATHEWS, M.B. (1996). Paradoxical interactions between human delta hepatitis agent RNA and the cellular protein kinase PKR. J. Virol. 70, 5611-5617.
118. CIRCLE, D.A., NEEL, O.D., ROBERTSON, H.D., CLARKE, P.A., and MATHEWS, M.B. (1997). Surprising specificity of PKR binding to delta agent genomic RNA. 3, 438-148.
119. ELIA, A., LAING, K.G., SCHOFIELD, A., TILLERAY, V.J., and CLEMENS, M.J. (1996). Regulation of the double-stranded RNA-dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein-Barr virus genome. Nucleic Acids Res. 24, 4471-4478.
120. KATZE, M.G. (1992). The war against the interferon-induced dsRNA-activated protein kinase: can viruses win? J. Interferon Res. 12, 241-248.
121. CLEMENS, M.J., LAING, K., JEFFREY, I.W., SCHOFIELD, A., SHARP, T.V., ELIA, A., MATYS, V., JAMES, M.C., and TILLERAY, V.J. (1994). Regulation of the interferon-inducible eIF-2α protein kinase by small RNAs. Biochimie 76, 770-778.
122. KATZE, M.G., DECORATO, D., SAFER, B., GALABRU, J., and HOVANESSIAN, A.G. (1987). The adenovirus VAI RNA complexes with the p68 protein kinase to regulate its autophosphorylation and activity. EMBO J. 6, 689-697.
123. MATHEWS, M.B., and SHENK, T. (1991). Adenovirus virus-associated RNA and translation control. J. Virol. 65, 5657-5662.
124. MELLITS, K.H., KOSTURA, M., and MATHEWS, M.B. (1990). Interaction of adenovirus VA RNA1 with the protein kinase DAI: nonequivalence of binding and function. Cell 61, 843-852.
125. CLARKE, P.A., PE'ERY, T., MA, Y., and MATHEWS, M.B. (1994). Structural features of adenovirus 2 virus-associated RNA required for binding to the protein kinase DAI. Nucleic Acids Res. 22, 4364-4374.
126. MELLITS, K.H., PE'EREY, T., and MATHEWS, M.B. (1992). Role of the apical stem in maintaining the structure and function of adenovirus virus-associated RNA. J. Virol. 66, 2369-2377.
127. MELLITS, K.H., and MATHEWS, M.B. (1988). Effects of mutations in stem and loop regions on the structure and function of adenovirus VA RNA1. EMBO J. 7, 2849-2859.
128. MA, Y., and MATHEWS, M.B. (1996). Secondary and tertiary structure in the central domain of adenovirus type 2 VA RNAI. RNA 2, 937-955.
129. GHADGE, G.D., MALHOTRA, P., FURTADO, M.R., DHAR, R., and THIMMAPAYA, B. (1994). In vitro analysis of virus-associated RNA I (VAI RNA): inhibition of the double-stranded RNA-activated protein kinase PKR by VAI RNA mutants correlates with the in vivo phenotype and the structural integrity of the central domain. J. Virol. 68, 4137-4151.
130. GUNNERY, S.A., RICE, A.P., ROBERTSON, H.D., and MATHEWS, M.B. (1990). Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 87, 8687-8691.
131. MELLITS, K.H., PE'ERY, T., MANCHE, L., ROBERTSON, H.D., and MATHEWS, M.B. (1990). Removal of double-stranded contaminants from RNA transcripts: synthesis of adenovirus VA RNA1 from a T7 vector. Nucleic Acids Res. 18, 5401-5406.
132. ROY, S., AGY, M., HOVANESSIAN, A.G., SONENBERG, N., and KATZE, M.G. (1991). The integrity of the stem structure of human immuondeficiency virus type 1 Tat-responsive sequence RNA is required for interaction with the interferon-induced 68,000-Mr protein kinase. J. Virol. 65, 632-640.
133. MAITRA, R.K., McMILLAN, N.A.J., DESAI, S., McSWIGGEN, J., HOVANESSIAN, A.G., SEN, G., WILLIAMS, B.R.G., and SILVERMAN, R.H. (1994). HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology 204, 823-827.
134. 1 and TAR RNAs. Virology 206, 511-519.
135. JAGUS, R., and GRAY, M.M. (1994). Proteins that interact with PKR. Biochimie 76, 779-791.
136. BENKIRANE, M., NEUVEUT, C., CHUN, R.F., SMITH, S.M., SAMUEL, C.E., GATIGNOL, A., and JEANG, K-T. (1997). Oncogenic potential of TAR RNA-binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J. 16, 611-624.
137. PARK, H., DAVIES, M.V., LANGLAND, J.O., CHANG, H.-W., NAM, Y.S., TARTAGLIA, J., PAOLETTI, E., JACOBS, B.L., KAUFMAN, R.J., and VENKATESAN, S. (1994). TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. Proc. Natl. Acad. Sci. USA 91, 4713-4717.
138. WU, S.Y., and KAUFMAN, R.J. (1996). Double-stranded (ds) RNA binding and not dimerization correlates with the activation of the dsRNA-dependent protein kinase (PKR). J. Biol. Chem. 271, 1756-1763.
139. KOROMILAS, A.E., ROY, S., BARBER, G.N., KATZE, M.G., and SONENBERG, N. (1992). Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257, 1685-1689.
140. MEURS, E., GALABRU, J., BARBER, G.N., KATZE, M.G., and HOVANESSIAN, A.G. (1993). Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 90, 232-236.
141. FENG, G., CHONG, K., KUMAR, A., and WILLIAMS, B.R.G. (1992). Identification of double-stranded RNA-binding domains in the interferon-induced double-stranded RNA-activated p68 kinase. Proc. Natl. Acad. Sci. USA 89, 5447-5451.
142. SHARP, T.V., XIAO, Q., JEFFREY, I., GEWERT, D.R., and CLEMENS, M.J. (1993). Reversal of the dsRNA-induced inhibition of protein synthesis by an inactive mutant of the protein kinase PKR. Eur. J. Biochem. 214, 945-948.
143. SHARP, T.V., XIAO, Q., JUSTESEN, J., GEWERT, D.R., and CLEMENS, M.J. (1995). Regulation of the interferon-inducible protein kinase PKR and (2′-5′)oligo(adenylate) synthetase by a catalytically inactive PKR mutant through competition for double-stranded RNA binding. Eur. J. Biochem. 230, 97-103.
144. BARBER, G.N., JAGUS, R., MEURS, E.F., HOVANESSIAN, A.G., and KATZE, M.G. (1995). Molecular mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of the interferon-induced enzyme RNA-dependent protein kinase. J. Biol. Chem. 270, 17423-17428.
145. BARBER, G.N., WAMBACH, M., THOMPSON, S., JAGUS, R., and KATZE, M.G. (1995). Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol. Cell. Biol. 15, 3138-3146.
146. PAIN, V.M. (1996). Initiation of protein synthesis in eukaryotic cells. Eur. J. Biochem. 236, 747-771.
147. ZHU, S., ROMAND, P.R., and WEK, R.C. (1997). Ribosome targeting of PKR is mediated by two double-stranded RNA-binding domains and facilitates in vivo phosphorylation of eukaryotic initiation factor-2. J. Biol. Chem. 272, 14434-14441.
148. KUMAR, A., HAQUE, J., LACOSTE, J., HISCOTT, J., and WILIAMS, B.R.G. (1994). Double-stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB. Proc. Natl. Acad. Sci. USA 91, 6288-6292.
149. MARAN, A., MAITRA, R.K., KUMAR, A., DONG, B., XIAO, W., LI, G., WILLIAMS, B.R.G., TORRENCE, P.F., and SILVERMAN, R.H. (1994). Blockage of NF-κB signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science 265, 789-792.
150. YANG, Y.-L, REIS, L.F.L., PAVLOVIC, J., AGUZZI, A., SCHAFER, R., KUMAR, A., WILLIAMS, B.R.G., AGUET, M., and WEISSMANN, C. (1995). Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase, PKR. EMBO J. 14, 6095-6106.
151. KUMAR, A., YANG, Y.-L., FLATI, V., DER, S., KADEREIT, S., DEB, A., HAQUE, J., REIS, L., WEISSMANN, C., and WILLIAMS, B.R.G. (1997). Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-κB. EMBO J. 16, 406-416.
152. KOROMILAS, A.E., CANTIN, C., CRAIG, A.W.B., JAGUS, R., HISCOTT, J., and SONENBERG, N. (1995). The interferon-inducible protein kinase PKR modulates the transcriptional activation of immunoglobulin kappa gene. J. Biol. Chem. 270, 25426-25434.
153. WONG, A.H.T., TAM, N.W.N., YANG, Y.L., CUDDIHY, A.R., LI, S.Y., KIRCHHOFF, S., HAUSER, H., DECKER, T., and KOROMILAS, A.E. (1997). Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 16, 1291-1304.
154. McMILLAN, N.A.J., CHUN, R.F., SIDEROVSKI, D.P., GALABRU, J., TOONE, W.M., SAMUEL, C.E., MAK, T.W., HOVANESSIAN, A.C., JEANG, K.T., and WILLIAMS, B.R.G. (1995). HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology 213, 413-424.
155. BRAND, S.R., KOBAYASHI, R., and MATHEWS, M.B. (1997). The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J. Biol. Chem. 272, 8388-8395.
156. JUDWARE, R., LI, J., and PETRYSHYN, R. (1993). Inhibition of the dsRNA-dependent protein kinase by a peptide derived from the human immunodeficiency virus type 1 Tat protein. J. Interferon Res. 13, 153-160.
157. CHEBATH, J., BENECH, P., HOVANESSIAN, A., GALABRU, J., and REVEL, M. (1987). Four different isoforms of interferon-induced 2′,5′-oligo(A) synthetase identified by immunoblotting in human cells. J. Biol. Chem. 262, 3852-3857.
158. KATZE, M. (1995). Regulation of the interferon-induced PKR: can viruses cope? Trends Microbiol. 3, 75-78.
159. LEE, S.B., MELKOVA, Z., YAN, W., WILLIAMS, B.R.G., HOVANESSIAN, A.G., and ESTEBAN, M. (1993). The interferon-induced double-stranded RNA-activated human p68 protein kinase potently inhibits protein synthesis in cultured cells. Virology 192, 380-385.
160. MEURS, E.F., WATANABE, Y., KADEREIT, S., BARBER, G.N., KATZE, M.G., CHONG, K., WILLIAMS, B.R.G., and HOVANESSIAN, A.G. (1992). Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J. Virol. 66, 5805-5814.
161. DER, S.D., and LAU, A.S. (1995). Involvement of the double-stranded-RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. Proc. Natl. Acad. Sci. USA 92, 8841-8845.
162. DAVIES, M.V., FURTADO, M., HERSHEY, J.W.B., THIMMAPPAYA, B., and KAUFMAN, R.J. (1989). Complementation of adenovirus virus-associated RNA I gene deletion by expression of a mutant eukaryotic translation initiation factor. Proc. Natl. Acad. Sci. USA 86, 9163-9167.
163. LEE, S.B., and ESTEBAN, M. (1993). The interferon-induced double-stranded RNA-activated human p68 protein kinase inhibits the replication of vaccinia virus. Virology 193, 1037-1041.
164. SWAMINATHAN, S., RAJAN, P., SAVINOVA, O., JAGUS, R., and THIMMAPAYA, B. (1996). Simian virus 40 large-T bypasses the translational block imposed by the phosphorylation of eIF-2α. Virology 219, 321-323.
165. CLEMENS, M. (1992). Suppression with a difference. Nature 360, 210-211.
166. LENGYEL, P. (1993). Tumor-suppressor genes: news about the interferon connection. Proc. Natl. Acad. Sci. USA 90, 5893-5895.
167. PETRYSHYN, R., CHEN, J.-J., and LONDON, I.M. (1984). Growth-related expression of a double-stranded RNA-dependent protein kinase in 3T3 cells. J. Biol. Chem. 259, 14736-14742.
168. PETRYSHYN, R., CHEN, J.-J., and LONDON, I.M. (1988). Detection of activated double-stranded RNA-dependent protein kinase in 3T3-F442A cells. Proc. Natl. Acad. Sci. USA 85, 1427-1431.
169. PETRYSHYN, R., CHEN, J.J., DANLEY, L., and MATTS, R.L. (1996). Effect of interferon on protein translation during growth stages of 3T3 cells. Arch. Biochem. Biophys. 326, 290-297.
170. MONTINE, K.S., and HENSHAW, E.C. (1989). Serum growth factors cause rapid stimulation of protein synthesis and dephosphorylation of eIF-2 in serum deprived Ehrlich cells. Biochim. Biophys. Acta 1014, 282-288.
171. MUNDSCHAU, L.J., and FALLER, D.V. (1995). Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. Immediate early gene induction. J. Biol. Chem. 270, 3100-3106.
172. MUNDSCHAU, L.J., and FALLER, D.V. (1992). Oncogenic ras induces an inhibitor of double-stranded RNA-dependent eukaryotic initiation factor 2α-kinase activation. J. Biol. Chem. 267, 23092-23098.
173. BANDYOPADHYAY, S.K., and SEN, G.C. (1992). Role of protein phosphorylation in activation of interferon-stimulated gene factors. J. Biol. Chem. 267, 6389-6395.
174. OFFERMANN, M.K., ZIMRING, J., MELLITS, K.H., HAGAN, M.K., SHAW, R., MEDFORD, R.M., MATHEWS, M.B., GOODBOURN, S., and JAGUS, R. (1995). Activation of the double-stranded-RNA-activated protein kinase and induction of vascular cell adhesion molecule-1 by poly(I).poly(C) in endothelial cells. Eur. J. Biochem. 232, 28-36.
175. LEW, D.J., DECKER, T., STREHLOW, I., and DARNELL, J.E. (1991). Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons. Mol. Cell. Biol. 11, 182-191.
176. TAKIZAWA, T. (1996). Mechanism of the induction of apoptosis by influenza virus infection. Nippon-Rinsho 54, 1836-1841.
177. NAGAI, K., WONG, A.H.T., LI, S.Y., TAM, N.W.N., CUDDIHY, A.R., SONENBERG, N., MATHEWS, M.B., HISCOTT, J., WAINBERG, M.A., and KOROMILAS, A.E. (1997). Induction of CD4 expression and human immunodeficiency virus type 1 replication by mutants of the interferon-inducible protein kinase PKR. J. Virol. 71, 1718-1725.
178. HISCOTT, J., ALPER, D., COHEN, L., LEBLANC, J.F., SPORTZA, L., WONG, A., and XANTHOUDAKIS, S. (1989). Induction of human interferon gene expression is associated with a nuclear factor that interacts with the NF-kappaB site of the human immunodeficiency virus enhancer. J. Virol. 63, 2557-2566.
179. LENARDO, M.J., FAN, C-M., MANIATIS, T., and BALTIMORE, D. (1989) The involvement of NF-kappaB in β-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 57, 287-294.
180. VISVANATHAN, K.V., and GOODBOURN, S. (1989). Double-stranded DNA activates binding of NF-βB to an inducible element in the human beta-interferon promoter. EMBO J. 8, 1129-1138.
181. REIS, L.F.L., HARADA, H., WOLCHOK, J.D., TANIGUCHI, T., and VILCEK, J. (1992). Critical role of a common transcription factor, IRF-1, in the regulation of IFN-β and IFN-inducible genes. EMBO J. 11, 185-193.
182. WHITESIDE, S.T., VISVANATHAN, K.V., and GOODBOURN, S. (1992). Identification of novel factors that bind to the PRD I region of the human beta-interferon promoter. Nucleic Acids Res. 20, 1531-1538.
183. ELLIS, M.J., and GOODBOURN, S. (1994). NF-kappa B-independent activation of beta-interferon expression in mouse F9 embryonal carcinoma cells. Nucleic Acids Res. 22, 4489-4496.
184. MEURS, E.F., McMILLAN, N., WILLIAMS, B.R.G., HOVANESSIAN, A.G., and SOUTHERN, P.J. (1995). Human PKR transfected into murine cells stimulates expression of genes under control of the HIV1 or HTLV-1 LTR. Virology 214, 653-659.
185. GUSELLA, G.L., MUSSO, T., ROTTSCHAFER, S.E., PULKKI, K., and VARESIO, L. (1995). Potential requirement of a functional double-stranded RNA-dependent protein kinase (PKR) for the tumoricidal activation of macrophages by lipopolysaccharide or IFN-αβ, but not IFN-gamma. J. Immunol. 154, 345-354.
186. WADA, N., MATSUMURA, M., OHBA, Y., KOBAYASHI, N., TAKIZAWA, T., and NAKANISHI, Y. (1995). Transcription stimulation of the Fas-encoding gene by nuclear factor for interleukin-6 expression upon influenza virus infection. J. Biol. Chem. 270, 18007-18012.
187. DALY, C, and REICH, N.C. (1995). Characterization of specific DNA-binding factors activated by double-stranded RNA as positive regulators of interferon α/β-stimulated genes. J. Biol. Chem. 270, 23739-23746.
188. DECKER, T. (1992). Double-stranded RNA and interferon-α induce transcription through different molecular mechanisms. J. Interferon Res. 12, 445-448.
189. BANDYOPADHYAY, S.K., LEONARD, G.T., Jr., BANDYOPADHYAY, T., STARK, G.R., and SEN, G.C. (1995). Transcriptional induction by double-stranded RNA is mediated by interferon-stimulated response elements without activation of interferon-stimulated gene factor 3. J. Biol. Chem. 270, 19624-19629.
190. HE, J., OLSON, J.J., EKSTRAND, A.J., SERBANESCU, A., YANG, J., OFFERMANN, M.K., and JAMES, C.D. (1996). Transfection of IFNα in human glioblastoma cells and tumorigenicity in association with induction of PKR and OAS gene expression. J. Neurosurg. 85, 1085-1090.
191. BARBER, G.N., THOMPSON, S., LEE, T.G., STROM, T., JAGUS, R., DARVEAU, A., and KATZE, M.G. (1994). The 58kDa inhibitor of the interferon induced dsRNA activated protein kinase is a TPR protein with oncogenic properties. Proc. Natl. Acad. Sci. USA 91, 4278-1282.
192. DONZÉ, O., JAGUS, R., KOROMILAS, A.E., HERSHEY, J.W.B., and SONENBERG, N. (1995). Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J. 14, 3828-3834.
193. MUNDSCHAU, L.J., and FALLER, D.V. (1994). Endogenous inhibitors of the dsRNA-dependent eIF-2α protein kinase PKR in normal and ras-transformed cells. Biochimie 76, 792-800.
194. RAVEH, T., HOVANESSIAN, A.G., MEURS, E.F., SONENBERG, N., and KIMCHI, A. (1996). Double-stranded RNA-dependent protein kinase mediates c-Myc suppression induced by type I interferons. J. Biol. Chem. 271, 25479-25484.
195. SENGUPTA, D.N., and SILVERMAN, R.H. (1989). Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA. Nucleic Acids Res. 17, 969-978.
196. MORDECHAI, E., KON, N., HENDERSON, E.E., and SUHADOLNIK, R.J. (1995). Activation of the interferon-inducible enzymes, 2′,5′-oligoadenylate synthetase and PKR by human T-cell leukemia virus type I Rex-response element. Virology 206, 913-922.
197. SAMUEL, C.E., and BRODY, M.S. (1990). Biosynthesis of reovirus-specified polypeptides: 2-aminopurine increases the efficiency of translation of reovirus si mRNA but not s4 mRNA in transfected cells. Virology 176, 106-113.
198. (r) 68,000 protein kinase by viroid strains of varying pathogenicity. Biochimie 75, 533-538.
199. MOHR, I., and GLUZMAN, Y. (1996). A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function. EMBO J. 15, 4759-4766.
200. THOMIS, D.C., and SAMUEL, C.E. (1992). Mechanism of interferon action: autoregulation of RNA-dependent P1/eIF-2α protein kinase (PKR) expression in transfected mammalian cells. Proc. Natl. Acad. Sci. USA 89, 10837-10841.
201. RASTINEJAD, F., CONBOY, M.J., RANDO, T.A., and BLAU, H.M. (1993). Tumor suppression by RNA from the 3′ untranslated region of α-tropomyosin. Cell 75, 1107-1117.
202. CLARKE, P.A., SHARP, N.A., ARRAND, J.R., and CLEMENS, MJ. (1990). Epstein-Barr virus gene expression in interferon-treated cells. Implications for the regulation of protein synthesis and the antiviral state. Biochim. Biophys. Acta 1050, 167-173.
203. UHLENBECK, O.C. (1995). Keeping RNA happy. RNA 1, 4-6.
204. GREEN, S.R., MANCHE, L., and MATHEWS, M.B. (1995). Two functionally distinct RNA-binding motifs in the regulatory domain of the protein kinase DAI. Mol. Cell. Biol. 15, 358-364.
205. FAVRE, D., STUDER, E., and MICHEL, M.R. (1996). Semliki Forest virus capsid protein inhibits the initiation of translation by upregulating the double-stranded RNA-activated protein kinase PKR. Biosci. Rep. 16, 485-511.
206. LEE, T.G., and KATZE, M.G. (1994). Cellular inhibitors of the interferon-induced, dsRNA-activated protein kinase. Prog. Mol. Subcell. Biol. 14, 48-65.
207. JUDWARE, R., and PETRYSHYN, R. (1992). Mechanism of action of a cellular inhibitor of the dsRNA-dependent protein kinase from 3T3-F442A cells. J. Biol. Chem. 267, 21685-21690.
208. LEE, T.G., TANG, N., THOMPSON, S., MILLER, J., and KATZE, M.G. (1994). The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol. Cell. Biol. 14, 2331-2342.
209. PETRYSHYN, R., LEVIN, D.H., and LONDON, I.M. (1982). Regulation of double-stranded RNA-activated eukaryotic initiation factor 2alpha kinase by type 2 protein phosphatase in reticulocyte lysates. Proc. Natl. Acad. Sci. USA 79, 6512-6516.
210. r = 68,000 initiation factor 2 kinase. J. Biol. Chem. 264, 3827-3831.
211. LANGLAND, J.O., PETTIFORD, S., JIANG, B., and JACOBS, B.L. (1994). Products of the porcine group C rotavirus NSP3 gene bind specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase PKR. J. Virol. 68, 3821-3829.
212. DAVIES, M.V., ELROY-STEIN, O., JAGUS, R., MOSS, B., and KAUFMAN, R.J. (1992). The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J. Virol. 66, 1943-1950.
213. DAVIES, M.V., CHANG, H.-W., JACOBS, B.L., and KAUFMAN, R.J. (1993). The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms. J. Virol. 67, 1688-1692.
214. CARROLL, K., ELROY-STEIN, O., MOSS, B., and JAGUS, R. (1993). Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2α-specific protein kinase. J. Biol. Chem. 268, 12837-12842.
215. LU, Y., WAMBACH, M., KATZE, M.G., and KRUG, R.M. (1995). Binding of the influenza virus NS1 protein to double-standed RNA inhibits the activation of the protein kinase that phosphorylates the eIF-2 translation initiation factor. Virology 214, 222-228.
216. XIAO, Q., SHARP, T.V., JEFFREY, I.W., JAMES, M.C., PRUIJN, G.J.M., VAN VENROOIJ, W.J., and CLEMENS, M.J. (1994). The La antigen inhibits the activation of the interferon-inducible protein kinase PKR by sequestering and unwinding double-stranded RNA. Nucleic Acids Res. 22, 2512-2518.
217. WU, S.Y., REHEMTULLA, A., GUPTA, N.K., and KAUFMAN, R.J. (1996). A eukaryotic translation initiation factor 2-associated 67 kDa glycoprotein partially reverses protein synthesis inhibition by activated double-stranded RNA-dependent protein kinase in intact cells. Biochemistry 35, 8275-8280.
218. HE, B., GROSS, M., and ROIZMAN, B. (1997). The gamma1 34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 94, 843-848.
219. KADEREIT, S., GALABRU, J., ROBERT, N., MEURS, E.F., and HOVANESSIAN, A.G. (1994). Characterization of an interferon-induced 48-kD protein immunologically related to the double-stranded RNA-activated protein kinase PKR. J. Interferon Res. 14, 251-257.
220. KADEREIT, S., GEWERT, D.R., GALABRU, J., HOVANESSIAN, A.G., and MEURS, E.F. (1993). Molecular cloning of two new interferon-induced, highly related nuclear phosphoproteins. J. Biol. Chem. 268, 24432-24441.
221. LEE, S.B., RODRIGUEZ, D., RODRIGUEZ, J.R., and ESTEBAN, M. (1997). The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bc1-2, and involves ICE-like proteases. Virology 231, 81-88.
222. DEVER, T.E., CHEN, J.-J., BARBER, G.N., CIGAN, A.M., FENG, L., DONAHUE, T.F., LONDON, I.M., KATZE, M.G., and HINNEBUSCH, A.G. (1993). Mammalian eukaryotic initiation factor 2α kinases functionally substitute for GCN2 protein kinase in the GCN4 translational control mechanism of yeast. Proc. Natl. Acad. Sci. USA 90, 4616-4620.
223. ORTEGA, L.G., McCOTTER, M.D., HENRY, G.L., McCORMACK, S.J., THOMIS, D.C., and SAMUEL, C.E. (1996). Mechanism of interferon action - biochemical and genetic evidence for the intermolecular association of the RNA-dependent protein kinase PKR from human cells. Virology 215, 31-39.
224. ROY, S., KATZE, M.G., PARKIN, N.T., EDERY, I., HOVANESSIAN, A.G., and SONENBERG, N. (1990). Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 247, 1216-1219.